Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

View:
Post by culater on Jun 24, 2010 1:02pm

Amazed

Could have sold at .42 c yesterday and bought today at .21 to watch it go to .42 again by August.  People will continue to speculate on this stock as there is not much else out there and it is as promising as anything. Do people really think that this would be the end, after all the confirmed results.  Paladin also has a stake here and I am sure they have some people who are qualified to assist both Lux and ISA while dotting i's and crossing t's.  These are significant sized companies. Don't know about you but any dealings I have had with Governments, yesterday is really no surprise.   Hope everyone is making money when they trade on news and hopefully aren't the one's buying high and selling low.  LOL

culater
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities